Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHemoCept Inc.
About this trial
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
Subjects can be any gender but must be age 18 or older.
Subject is able and willing to provide informed consent and HIPAA authorization.
Subject is able and willing to meet all study requirements.
Disqualifiers
Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Trial population
Subjects above the age of 18 who meet all inclusion/exclusion criteria.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Association between device measurements and Pulmonary Capillary Wedge Pressure
The correlation of HemoCept device measurements to Pulmonary Capillary Wedge Pressure (PCWP) measured during right heart catheterization.
Time frame
Day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov